Abstract
In vitro tests were carried out on Dacron® samples differently knitted and on Dacron® vascular prostheses coated with various urethanes. All the materials were put in contact with human platelet-rich plasma; the subsequent assay of three platelet released substances, i.e. β-thromboglobulin, platelet factor 4 and thromboxane B2, as well as the quantification of platelet retention, were used to establish the degree of thrombogenicity of the material itself. In some cases Dacron®-urethanes composites showed better thromboresistance than any other materials conventionally used in vascular surgery.
| Original language | English |
|---|---|
| Pages (from-to) | 441-444 |
| Number of pages | 4 |
| Journal | Biomaterials |
| Volume | 10 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1989 |
Fingerprint
Keywords
- Dacron®
- platelets
- release reaction
- Thrombogenicity
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Biomedical Engineering
Cite this
Comparative study of the thromboresistance of Dacron® combined with various polyurethanes. / Leake, D. L.; Cenni, E.; Cavedagna, D.; Stea, S.; Ciapetti, G.; Pizzoferrato, A.
In: Biomaterials, Vol. 10, No. 7, 1989, p. 441-444.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Comparative study of the thromboresistance of Dacron® combined with various polyurethanes
AU - Leake, D. L.
AU - Cenni, E.
AU - Cavedagna, D.
AU - Stea, S.
AU - Ciapetti, G.
AU - Pizzoferrato, A.
PY - 1989
Y1 - 1989
N2 - In vitro tests were carried out on Dacron® samples differently knitted and on Dacron® vascular prostheses coated with various urethanes. All the materials were put in contact with human platelet-rich plasma; the subsequent assay of three platelet released substances, i.e. β-thromboglobulin, platelet factor 4 and thromboxane B2, as well as the quantification of platelet retention, were used to establish the degree of thrombogenicity of the material itself. In some cases Dacron®-urethanes composites showed better thromboresistance than any other materials conventionally used in vascular surgery.
AB - In vitro tests were carried out on Dacron® samples differently knitted and on Dacron® vascular prostheses coated with various urethanes. All the materials were put in contact with human platelet-rich plasma; the subsequent assay of three platelet released substances, i.e. β-thromboglobulin, platelet factor 4 and thromboxane B2, as well as the quantification of platelet retention, were used to establish the degree of thrombogenicity of the material itself. In some cases Dacron®-urethanes composites showed better thromboresistance than any other materials conventionally used in vascular surgery.
KW - Dacron®
KW - platelets
KW - release reaction
KW - Thrombogenicity
UR - http://www.scopus.com/inward/record.url?scp=0024313896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024313896&partnerID=8YFLogxK
U2 - 10.1016/0142-9612(89)90083-5
DO - 10.1016/0142-9612(89)90083-5
M3 - Article
C2 - 2529915
AN - SCOPUS:0024313896
VL - 10
SP - 441
EP - 444
JO - Biomaterials
JF - Biomaterials
SN - 0142-9612
IS - 7
ER -